Home
>
National Drug Code (NDC)
>
Angiomax
Angiomax - 55154-2275-5 - (bivalirudin)
Drug Information of Angiomax
| Product NDC: | 55154-2275 |
| Proprietary Name: | Angiomax |
| Non Proprietary Name: | bivalirudin |
| Active Ingredient(s): | 250 mg/1 & nbsp; bivalirudin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Angiomax
| Product NDC: | 55154-2275 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020873 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20001215 |
Package Information of Angiomax
| Package NDC: | 55154-2275-5 |
| Package Description: | 5 VIAL, SINGLE-USE in 1 BAG (55154-2275-5) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
NDC Information of Angiomax
| NDC Code | 55154-2275-5 |
| Proprietary Name | Angiomax |
| Package Description | 5 VIAL, SINGLE-USE in 1 BAG (55154-2275-5) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
| Product NDC | 55154-2275 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | bivalirudin |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20001215 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | BIVALIRUDIN |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
